KRISHNA PATEL: Open Payments
NPI 1992037550 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 38 payments from 13 companies in 2025. Trend: 2023 $436 · 2024 $397 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $190 |
| GENZYME CORPORATION | 8 | $144 |
| Galderma Laboratories, L.P. | 2 | $64 |
| Lilly USA, LLC | 2 | $58 |
| ABBVIE INC. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Organon LLC | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, TALTZ, RINVOQ, Sotyktu, COSENTYX, VTAMA.
Industry payments across CA — which companies pay providers there.
